T. Rowe Price Associates, Inc. 13D and 13G filings for Avidity Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-14 12:19 pm Sale | 2025-09-30 | 13G | Avidity Biosciences, Inc. RNA | T. Rowe Price Associates, Inc. | 9,787,912 7.100% | -846,050 (-7.96%) | Filing |
| 2024-11-14 1:22 pm Purchase | 2024-09-30 | 13G | Avidity Biosciences, Inc. RNA | T. Rowe Price Associates, Inc. | 10,633,962 9.000% | 977,110 (+10.12%) | Filing |
| 2024-03-11 1:12 pm Purchase | 2024-02-29 | 13G | Avidity Biosciences, Inc. RNA | T. Rowe Price Associates, Inc. | 9,656,852 12.100% | 2,738,942 (+39.59%) | Filing |
| 2024-02-14 10:03 am Purchase | 2023-12-31 | 13G | Avidity Biosciences, Inc. RNA | T. Rowe Price Associates, Inc. | 6,917,910 9.300% | 210,623 (+3.14%) | Filing |
| 2023-02-14 12:38 pm Purchase | 2022-12-31 | 13G | Avidity Biosciences, Inc. RNA | T. Rowe Price Associates, Inc. | 6,707,287 10.100% | 1,627,761 (+32.05%) | Filing |
| 2022-08-10 2:56 pm Sale | 2022-07-31 | 13G | Avidity Biosciences, Inc. RNA | T. Rowe Price Associates, Inc. | 5,079,526 10.200% | -2,652,320 (-34.30%) | Filing |
| 2022-02-14 2:35 pm Purchase | 2021-12-31 | 13G | Avidity Biosciences, Inc. RNA | T. Rowe Price Associates, Inc. | 7,731,846 16.400% | 1,916,636 (+32.96%) | Filing |
| 2021-09-10 1:36 pm Purchase | 2021-08-31 | 13G | Avidity Biosciences, Inc. RNA | T. Rowe Price Associates, Inc. | 5,815,210 12.700% | 5,815,210 (New Position) | Filing |